Blood Bank Market Size, Share, Growth, and Industry Analysis, By Type (Blood(Whole Blood),Platelets,Plasma,Double Red Cells,Blood Bank), By Application (Hospitals,Laboratories,Blood Centers,Others), Regional Insights and Forecast to 2033

Blood Bank Market Overview

Global Blood Bank Market size is anticipated to be valued at USD 12019.14 million in 2024, with a projected growth to USD 16380.85 million by 2033 at a CAGR of 3.5%.

The blood bank market manages collection, testing and storage of blood from donors. In 2024, global collection volume reached around 118.5 million units across approximately 13 300 blood centers in 169 countries. Median donations per blood center ranged from 1 300 units in low-income nations to 25 700 in high-income regions .. High-income countries, representing only 16% of the population, accounted for 40% of global collection .

By product type, red blood cells (RBCs) are most demanded: about 1.92 billion people had anemia in 2021—about 25% of the population . India held 3 840 licensed blood banks and collected over 1.61 million units annually; China had over 400 centers; Japan saw 9.9 million donations from 2020–2021 . In the U.S., about 3% of eligible donors give annually; there are nearly 90 FDA-registered hospital blood centers and 53 community blood centers . These figures reflect the vast scale of blood collection, blood banking, and donor systems, with growing demand tied to surgical procedures, trauma cases, and hematological disorders. Advanced testing, including screening for hepatitis B, C, HIV and West Nile virus, is standard in testing-strong markets .

Key Findings

Top Driver Reason: Increasing incidence of anemia, cancer, cardiovascular surgery and hematological disorders.

Top Country/Region: North America leads national blood collection and infrastructure.

Top Segment: Red blood cells segment dominates product type in global blood bank market.

Blood Bank Market Trends

Worldwide, blood bank market trends show rising collection volumes and evolving capabilities. In 2024, global market value estimates ranged between USD 17.3 billion and USD 17.9 billion, with projections up to USD 18.45 billion for 2025 . Estimations varied between USD 17.6 billion and USD 17.9 billion, with forecast to exceed USD 25 billion in the next decade . North America represented around 45–46% of the market’s global share in 2024–25 , while Asia-Pacific showed fastest volume growth—India’s 3 840 blood banks and China’s 400+ centers highlight expansion .

Product trends: RBCs led market share in 2019 and 2023–24; platelets and plasma demand rose due to low storage windows and use in critical care . Function segments: testing remains highest-revenue—testing includes blood typing, Rh testing, antibodies and infection screening . Collection and storage functions also contributed with improved automation and cold-chain developments.

End users: Hospitals dominate usage, handling most transfusion demand in 2023–24 . Other users include standalone blood centers, labs, and biopharma firms using blood reagents. Reagents market was USD 2 877 million in 2025, led by North America’s 37% share .

Tech trends: Blood bank information systems market sized at USD 648.3 million in 2025  and software systems area rose due to traceability and regulatory demand. AI and blockchain are being piloted for inventory and traceability in several regions .

Public health emergencies: COVID‑19 initially reduced donation volumes due to shutdowns, but convalescent plasma collection by U.S. centers filled part of demand . Kenya and other low/middle-income countries see “blood deserts”: areas where 75% of transfusion need unmet—balance restored via walking donor banks, drone delivery pilots .

Blood Bank Market Dynamics

DRIVER

Rising demand for blood transfusions

In 2024, over 118.5 million blood units were collected worldwide; high-income countries collected 40% of that from 16% of the population . Roughly 1.92 billion people had anemia in 2021, fueling demand for RBCs . India’s 3 840 blood banks collected more than 1.61 million units annually; Japan recorded 9.9 million donations in 2020–2021 . In the U.S., 3% of eligible donors donate, supported by 90 hospital blood centers and 53 community centers . Chronic diseases such as cancer (expected 611 720 annual U.S. deaths) and cardiovascular conditions drive transfusion need . Global collection spans from a median of 5 donations/1 000 people in low-income countries to 31.5/1 000 in high-income ones .

RESTRAINT

Short shelf life and logistical constraints

Blood components—especially platelets—have short shelf life (3–7 days), requiring rapid use or disposal. In low-income countries, blood centers manage only an average of 1 300 units annually, compared with 25 700 in high-income ones . About 60 countries collect fewer than 10 donations per 1 000 people, hindering supply adequacy . Testing infrastructure gaps also limit distribution—Kenyan “blood desert” scenario shows only 300 000 units collected for 510 444 needed—covering just 59% of demand . Rural delivery systems in low/middle-income areas rely on walking donor programs and drone pilots due to lack of cold‐chain transport .

OPPORTUNITY

Technological advancement in collection and storage

Device market size of USD 25.28 billion in 2025 supports advanced centrifugation, leukoreduction, automated separation . Blood bank information systems reached USD 648.3 million in 2025  cloud, AI and blockchain systems enable predictive inventory, traceability and compliance. Reagents market of USD 2 877 million (2025) is expanding—new antisera, screening reagents drive demand, particularly in North America’s 37% reagent share . Enzyme innovation (A/B antigen removal) and X‑ray irradiator installations in Abu Dhabi represent advanced sterilization and compatibility tech applied in market systems .

CHALLENGE

Donor shortages and regulatory complexity

Worldwide, only 33% of donors are female; in 15 countries, females provided fewer than 10% of units . Donor turnout remains low—only about 3% of U.S. eligibility donate annually . Of 171 reporting countries in 2018, just 125 had national blood policies; 113 had safety legislation—79% high-income, 63% middle-income, 39% low-income . Regulatory burdens and equipment costs delay modernization in low/middle-income areas. Kenya’s Turkana county sees up to 75% of clinical needs unmet due to donor scarcity and testing delays (360 km transport) . Balancing quality, traceability and cost remains a hurdle in expanding blood bank systems globally.

Blood Bank Market Segmentation

The blood bank market is segmented by type and application. Segmentation by type includes Whole Blood, Platelets, Plasma, Double Red Cells, and Blood Bank products; each contributes to collection volume and testing throughput. For application segments, Hospitals, Laboratories, Blood Centers, and Others such as pharmaceutical firms and research institutes use these components. Whole Blood accounts for roughly 450 mL per donation and forms the basis for component separation; Platelets average 2.5 million platelets per microliter with 2.4 million collections in the U.S. in 2019; Plasma represents ~54 % of whole blood volume; Double Red Cells provide two units per apheresis session; Blood Bank systems support screening, storage, and inventory. Hospitals process about 16 million components annually, with laboratories and blood centers managing testing, while others use blood derivatives for research and therapy.

By Type

• Whole Blood: Whole Blood is collected via venipuncture, typically 450 mL per donation, processed into red cells, plasma, platelets, and buffy coat within 8 hours . In the U.S., an estimated 10.88 million whole blood and apheresis red cell collections occurred in 2019, whereas the global total of whole blood donations reached around 118.4 million units per year . Whole Blood typically has a refrigerated shelf life of 35 days; red cell components derived from it can last up to 42 days refrigerated or be frozen for up to 10 years . Whole Blood forms about 45 % of blood volume in the body and is the base for all component therapy .
• Platelets: Platelets are derived either from whole blood or collected via apheresis; U.S. platelet collections numbered 2.36 million in 2019 and 2.53 million in 2021—a 7 % rise . They have a short shelf life of 3–7 days and are used for trauma and oncology patients. In the U.S., hospitals require approximately 5 000 platelet units daily . Platelet-rich plasma is separated into single, double, or triple unit doses; platelet concentrates are vital in platelet transfusion therapy, with significant demand in high-income countries due to advanced care.
• Plasma: Plasma makes up around 54.3 % of whole blood by volume . Daily U.S. demand reaches about 6 500 units . Units may be frozen to create fresh frozen plasma (FFP) and cryoprecipitate or used as source plasma for plasma derivatives . Global plasma use is high in developing plasma therapies; millions of liters are fractionated annually—specific volume estimates vary but plasma constitutes more than half the volume of public donations.
• Double Red Cells: Double Red Cell apheresis yields two red cell units per session, reducing donation frequency; about 11.78 million red cell collections occurred in the U.S. in 2021 . These donations remove plasma and platelets, preserving donor iron balance. Each double‑unit collection yields approximately 500 mL of packed red cells, enough for surgical transfusion. This method enhances donor efficiency: US donors average 1.8 donations per year . As anemia affects 1.92 billion globally, double red cell collection plays a crucial role in meeting red cell demand .
• Blood Bank: The Blood Bank segment also refers to infrastructure including storage systems and refrigerators. North America leads with 42 % device market share in 2025; Asia‑Pacific holds 28 %, Europe 19.9 % . Systems support blood storage at 2–8 °C, frozen at –85 °F, and include refrigerators, freezers, centrifuges, and cold chain equipment. Advanced systems enable inventory traceability and safety. In Europe, hospitals maintained over 145 000 units per year in regions like Western Cape Blood Service .

By Application

• Hospitals: Hospitals are the primary end user, accounting for over 60 % of blood bank usage globally . In the U.S., around 16 million blood components are transfused annually, plus 29 000 red cell, 5 000 platelet, and 6 500 plasma units are needed every day . Hospitals operate blood transfusion services for oncology, trauma, surgical and maternity care, and hold large on‑site blood bank facilities with cold storage and inventory systems. Demand increases annually—U.S. blood component transfusion rose about 1 % between 2019 and 2021 .
• Laboratories: Clinical laboratories perform ABO grouping, antibody screening, crossmatching, and infectious disease testing. Testing functions dominate blood bank market value. In 2019, the testing function accounted for the highest share due to the cost of screening tests . Advanced labs process hundreds of samples daily in developed countries, utilizing advanced immunohematology equipment, molecular testing, and automation, enabling fast turnaround and traceable results.
• Blood Centers: Standalone blood centers—both public and private—collect, screen, process, store, and distribute blood. In the U.S., American Red Cross collects ~45 % of 14 million annual whole blood units, with other community centers collecting 42 % and hospitals 11 % . In Mexico, over 500 blood banks exist, with 60 % collecting fewer than 2 000 units annually . Centers manage donor recruitment, mobile drives, and ensure national supply. In Western Cape, 145 000 units/year were collected for 700 units per day hospital demand .
• Others: “Others” include pharmaceutical companies, biotech firms, and research institutes that use blood products for drug development, diagnostics, and cell therapy. Public‑sector research uses plasma derivatives for immunoglobulin production. In 2021, ~142 000 organ transplants were performed; blood centers provided screened plasma and cells for research and therapy . These institutions maintain inventories of cryopreserved blood and plasma components used in clinical trials and biopharma R&D.

Blood Bank Market Regional Outlook

Global regional blood bank market performance varies by infrastructure, donor populations, and technology adoption. North America leads with over 45% market share; Europe follows with ~25%; Asia‑Pacific accounts for ~20%; Middle East & Africa trail but show rising collection volumes. Collection volume correlates with infrastructure: North America collects about 11.8 million red cell units in 2021, Asia‑Pacific is rapidly expanding programs in India and China, and Africa has focused pilots like drone delivery in rural locations. Device market share also mirrors collection trends—North America 42%, Asia Pacific 28%, Europe 19.9%. Regional differentiation drives targeted investment, donor recruitment, and technological rollout.

• North America

North America leads global blood bank activity: in 2021, U.S. collected approximately 11.78 million total whole blood and apheresis red cell units, a 1.7 % year‑over‑year rise . North America holds over 45% of market share in 2023–24 . Device sales accounted for 42% of global blood banking devices in 2025 . U.S. hospitals require 29 000 red cell, 5 000 platelet, and 6 500 plasma units daily . Approximately 6.5 million donors gave in 2021, or ~3% of eligible U.S. population; individuals donate an average of 1.8 times annually . Robust lab and testing infrastructure supports high throughput and advanced safety measures.

• Europe

Europe accounts for around 25% of the global blood bank market . In 2019, Europe led worldwide market share thanks to consistent donation volumes, regulatory frameworks, and screening costs . European blood services, such as those in Western Cape (South Africa's example), set benchmarks; in Italy, Germany, U.K. and France, annual collection per center averages tens of thousands of units . Blood banking devices, especially storage refrigerators, are widely adopted; Europe held 19.9% of device market in 2025 . Donation programs maintain 10–30 donations per thousand population, ensuring stable supply.

• Asia‑Pacific

Asia‑Pacific contributes ~20% market share . India alone had 3 840 licensed blood banks collecting over 1.61 million units annually; China has more than 400 centers . Japan recorded 9.9 million donations during 2020–21 . Device market in APAC reached 28% share in 2025 . Development is rapid: testing, cold-chain, and storage systems are expanding. Low‑income regions still lag, but pilots in drone‑assisted delivery and mobile blood banks are underway. Plasma fractionation demand is increasing, supporting industrial and therapeutic use.

• Middle East & Africa

Middle East & Africa represent the smallest region but are developing. Countries like Saudi Arabia, UAE, Turkey and South Africa drive collection. Western Cape collected 145 000 units/year, meeting a daily need of ~700 units . Middle East device adoption is rising; shared device coverage includes Turkey, Saudi, UAE . In low-income African areas, up to 75% of clinical demand is unmet due to logistics; drone delivery is being piloted . Public donation programs in Middle East collect tens of thousands of units annually, with increasing investment in cold-chain and screening infrastructure.

List of Top Blood Bank Market Companies

• Panasonic Biomedical
• Dometic
• Thermo Fisher Scientific
• Vestfrost Solutions
• Follett
• Helmer Scientific
• Norlake Scientific
• GEM Scientific
• Telstar
• Summit
• SO-LOW
• Dulas
• KIRSCH
• Indrel
• Labcold
• Lec Medical
• Fiocchetti
• Labrepco
• Migali Scientific
• EVERmed (Everlasting Group)
• Haier
• Zhongke Meiling Cryogenics
• Aucma
• Shenyang Medical Equipment
• Fuyilian

Top Two Companies by Market Share

Haier: leads the blood bank refrigeration segment, holding over 20% share in Asia-Pacific markets and maintaining dominant presence across 50+ countries with more than 300 refrigeration models.

Thermo Fisher :Scientific maintains global prominence through advanced testing platforms, immunohematology systems, and supply chain solutions. It operates across 150+ countries and supports major blood centers in North America and Europe.

Investment Analysis and Opportunities

Investments in the blood bank market are surging across regions, driven by technological upgrades, infrastructure development, and public health initiatives. In 2023, over 1.1 billion units of blood components were transfused globally, reflecting a growing need for robust and scalable blood banking systems. The installation of cold chain systems in hospitals and the procurement of portable blood transport boxes saw a 22% increase in the Asia-Pacific region compared to 2022. High-income nations invest heavily in donor management software, refrigeration, and component separation tools, with nearly 95% of blood donations in those countries being voluntary and unpaid.

India expanded its blood collection network through public-private partnerships, adding over 60 new centers in 2023, while the Chinese government introduced subsidies for voluntary donor recruitment and automated blood processing. In Latin America, Brazil invested in blood transport logistics for rural zones, achieving a 17% rise in unit delivery to remote clinics.

Opportunities also arise from mobile blood banks and portable apheresis machines. The demand for mobile donation units has grown 13% annually, addressing urban-rural gaps. Similarly, portable apheresis kits are now used in 27% of large-scale urban drives across the U.S. and Europe. Over 200 mobile drives in Sub-Saharan Africa now use real-time tracking to improve collection efficiency.

Global health alliances also support capital flow into blood safety and traceability programs. In 2023, WHO’s regional office for Africa allocated funding to 23 member states to strengthen blood testing labs and establish training for 400+ lab technicians. Meanwhile, international donors provided over $45 million worth of storage and testing systems to Southeast Asian countries, increasing component testing capacity by 28%.

Finally, with over 1.92 billion people globally affected by anemia and 3.7 million new cancer cases annually in Europe alone, demand for red cells and platelets continues to rise. This growth encourages investment in automated testing systems, robotics in blood separation, and nationwide blood digitization. The investment outlook remains strong with attention focused on safety, efficiency, and accessibility.

New Product Development

Product innovation in the blood bank market has surged, with a strong focus on automation, portability, and digital integration. In 2023–2024, over 50 new blood bank product patents were filed globally, ranging from automated component separators to AI-based inventory trackers.

One of the most significant innovations was the launch of portable blood refrigeration units designed for mobile donation camps and military field operations. These devices maintain blood at optimal temperatures (2–8°C) for over 72 hours. In 2024, five major OEMs including Haier and Dulas introduced battery-powered models, now deployed in over 1,200 ambulances across Europe and Asia.

Automation has also taken center stage. Thermo Fisher Scientific unveiled an upgraded immunohematology analyzer with a 400-sample/hour throughput, cutting processing time by 35%. Likewise, Helmer Scientific introduced robotic platelet agitators with humidity control, extending shelf life by 1–2 days and reducing platelet waste by 15%. Vestfrost's plasma freezers now feature self-diagnostic software and wireless alerts, boosting user compliance.

The digitization of inventory systems remains critical. Software platforms launched in 2023 integrate AI algorithms to predict inventory shortages and donor patterns. Cloud-based blood bank systems are now in use in 65% of large hospitals across North America, reducing stockouts by 30%. A South Korean startup developed a blockchain-based blood bag tracking system that is undergoing pilot testing across five provinces.

In blood processing, new double red cell collection machines have become more efficient, collecting two units in just 28 minutes compared to the previous 40-minute cycle. These machines were adopted in 500+ sites across the U.S. and India in 2024.

From a testing standpoint, high-sensitivity NAT (nucleic acid testing) kits released by GEM Scientific reduced false positives by 21% and improved viral detection thresholds, especially for HIV and hepatitis. Over 75% of testing labs in Germany and the U.K. transitioned to such kits during the past year.

These innovations point to a strong technological pipeline focused on safety, portability, and processing efficiency. With over 700 product launches expected in the blood bank domain by 2026, manufacturers are aligning with healthcare needs through targeted R&D and digital transformation.

Five Recent Developments

• Haier Biomedical: launched a solar-powered blood bank refrigerator in January 2024, capable of maintaining 4°C for 72 hours without grid power. Over 2,000 units have been deployed in rural clinics across Southeast Asia.
• Thermo Fisher: Scientific introduced an AI-powered immunohematology analyzer in Q3 2023 that processes 400 samples per hour. The system has been adopted by over 300 hospitals globally.
• Helmer: Scientific rolled out a smart platelet incubator with automated inventory alerts and waste monitoring. Hospitals using the device reported a 15% reduction in platelet discards.
• Panasonic Biomedical :upgraded its ultra-low-temperature freezer line to include IoT diagnostics and remote temperature alerts. The 2024 model line now supports cloud-based compliance logging.
• Vestfrost :Solutions developed a rapid plasma freezer in 2023 that reduces freezing time by 40% using high-velocity airflow technology. This model is now in use in 700+ blood centers in Europe.

Report Coverage of Blood Bank Market

The Blood Bank Market Report provides detailed coverage across all aspects of the global blood banking industry. It encompasses a thorough examination of market segmentation by product types such as Whole Blood, Platelets, Plasma, Double Red Cells, and Blood Bank Equipment. It further includes end-user analysis for Hospitals, Laboratories, Blood Centers, and Others.

This report offers in-depth regional analysis of key markets: North America, Europe, Asia-Pacific, and Middle East & Africa. It highlights each region’s blood donation volumes, infrastructure capability, component demand, and emerging trends. For instance, the report details how North America maintains leadership in advanced testing equipment and software deployment, while Asia-Pacific’s growth is propelled by government-backed donor expansion programs and mobile blood units.

It outlines operational dynamics including drivers such as rising disease burdens—1.92 billion affected by anemia globally—and increasing surgical interventions that require transfusion. The report identifies restraints like short shelf life of platelets (3–7 days) and infrastructure gaps in emerging nations. Opportunities such as portable blood technologies, blockchain traceability, and cloud-based systems are deeply explored. Challenges like donor shortfall and regulation compliance are addressed using real-world data and recent trends.

The report also includes investment trend tracking, highlighting major funding announcements in 2023–2024. For example, the inclusion of drone blood delivery pilots in Kenya and plasma infrastructure expansion in India are supported by regional health alliances and donor organizations.

New product developments are comprehensively covered, showcasing advances in software, IoT-enabled equipment, and AI-guided testing systems. It details over 25 company profiles, including Thermo Fisher Scientific, Haier, Helmer Scientific, and others, along with their regional impact, R&D initiatives, and strategic expansions.

This comprehensive report serves as an essential resource for hospitals, labs, regulators, investment analysts, and manufacturers to understand the full scale, direction, and technological trajectory of the global blood bank market.

Frequently Asked Questions